Skip to content
problem genome

One of 592 unsolved problems in the Problem Genome, a collection written up for student design and engineering teams.

health

the light is on, the resident is in bed

Nursing homes are buying ceiling "biodynamic" lighting for residents with dementia, but a 12-month Dutch trial found no significant effect on sleep or daily rhythm while care routines may have kept many in bed; a US trial that put light where each resident sat did better, and the wearable sensors that show each resident's dose were often lost or removed

Source: Prins et al., “Biodynamic lighting versus bright light effects on…” Open ↗source: primaryLast updated: 2026-11-17

Problem statement

People with dementia who live in nursing homes see little daylight, and the light that sets the body clock has to reach the eye to work. Light boxes need a resident to sit in front of them for at least an hour, which a Dutch team calls impractical in nursing homes, and ceiling bright-light installations need many fittings and cost a lot. What homes are now buying is "biodynamic" ceiling lighting that changes brightness and colour through the day. The same team says it is popular because it fits care-technology trends and the wish to cut staff work, and because of "active promotion by lighting companies." When that team tested it for a year in a Dutch nursing home, neither biodynamic lighting nor bright light had a significant effect on residents' sleep or daily rest-activity rhythm (the study was small, not randomised and, by the authors' account, underpowered). The lights follow a schedule set for the room. The residents' days follow another pattern, which care routines and staffing may shape: bedtimes from 7–8 PM to 8–9 AM, an afternoon rest hour, and help needed to get out of bed. Research teams have done better in two ways. They have placed light where each resident actually sits, and that has improved sleep ratings and behaviour in a US trial. They have also clipped small light sensors on residents to record each person's dose. But in a US study of residents with dementia those sensors were often lost, broken or removed, and they worked poorly at night. The unsolved problem is getting enough light to the eyes of residents who spend much of the day in bed or in their own rooms, in a form a home can run, and knowing whether it got there without asking the resident to wear something.

Why this matters

Disturbed sleep and night-time restlessness are common in dementia. The Danish authors note that fragmented rhythms and evening agitation do not fit nursing-home schedules with fewer staff in the evening and at night, and that this helps explain heavy use of psychotropic drugs. Homes invest in lighting partly because it promises not to add staff work, but a US team setting up a lighting trial found nursing-home leaders worried about regulations and about added staff work. A 2025 systematic review of 144 controlled trials of sleep treatments in cognitive impairment found bright light therapy the most studied non-drug treatment, with "equivocal" results, and concluded there is insufficient evidence on which to base clinical decisions.

What’s been tried and why it hasn’t worked

(1) Biodynamic ceiling lighting in a Dutch nursing home (Prins et al. 2026). Forty-two residents with dementia took part in a non-randomised 12-month crossover. Tuneable ceiling luminaires in two ward living rooms ran a biodynamic schedule (6,000 K in the morning to 2,700 K in the evening, up to 2,500 lux horizontally). Then came standard light, then bright light (at least 1,000 lux at the cornea, 10 AM to 6 PM), then standard light again, three months each. Sleep was measured by wrist actigraphy and bed sensors. Neither lighting condition significantly changed any rest-activity or night-time sleep measure, or night-time bed exits, against baseline, and the two did not differ from each other. The authors point to poor sleep hygiene: a scheduled afternoon rest hour (with lower light in the biodynamic scheme), early bedtimes and long time in bed. The bedtimes, they write, "likely did not fully reflect individual sleep needs, but may instead have been influenced by institutional care routines and limited evening activities." They measured lux in the living rooms but not in hallways or personal rooms, and residents may have taken in daylight by sitting near windows. They conclude that "lighting interventions alone, without simultaneous behavioral or environmental adjustments, may be insufficient," and that one uniform lighting schedule for all residents is not recommended. They also call the study underpowered and ask for larger trials. (2) Dynamic lamps in residents' own apartments (Denmark, Baandrup and Jennum 2021). Seven controlled lamps were installed in each of 12 residents' 30 m² apartments for four weeks; 12 controls kept normal lighting. Rest-activity fragmentation improved briefly early on, but nothing else differed. Residents were in their apartments during the daily light boost on 69% of days (range 18–100%). The authors found that activity "was highly influenced by the staff situation." Many residents depended on staff to get out of bed, and this "seemed to be a stronger determinant" of activity than the light. They name the "lack of objective measurement of light exposure for each individual resident" as a limitation. (3) Ceiling bright light in Norway (Hjetland et al. 2021). A 24-week cluster-randomised, placebo-controlled trial in 8 nursing-home units (69 residents) used ceiling LED fittings giving 1,000 lux at 6,000 K from 10:00 to 15:00. Staff-rated sleep improved at weeks 16 and 24, but actigraphy showed no matching change. (4) Light placed where each resident sits (US, Figueiro et al. 2019). A randomised, placebo-controlled crossover trial with 46 residents with dementia in 8 long-term care facilities used floor lamps, light boxes and light tables. They were placed in each resident's bedroom or in the common area where that resident spent the day, timed to each person's usual wake time and aimed at a dose at the eye. Each resident wore a light meter as a pendant. Sleep-quality scores, rhythm fragmentation, depression and agitation scores improved against control. The authors note very low activity levels made objective sleep hard to analyse. This approach needs fittings chosen and placed for each resident by the research team. (5) Measuring each resident's dose with a wearable sensor (US, Jao, Wang and colleagues, 2024–2025). In a cluster-randomised crossover trial of an automatic daylight-linked lighting system in two Pennsylvania nursing homes, 27 residents wore a small light sensor clipped at the collar. The system reduced some neurobehavioral symptoms (sleep quality did not change significantly in an 18-resident pilot), and residents' own recorded dose tracked their symptoms. In a related comparison in 29 residents from two nursing homes, measured dose averaged 268 lux, while spot readings of the rooms they used averaged 85–114 lux, so room readings were a poor guide to what each person received. But the sensors were hard to keep on: 52 sensors were lost or broken, about 1 hour of daytime and 7 hours of night-time data were missing per resident per day, and some residents found the sensors uncomfortable or removed them. The team reports a 40% loss or damage rate and calls for "more discreet, lightweight, and tamper-resistant sensor designs" (conference abstracts and one full paper). (6) Other positive results. A 2025 Korean meta-analysis of nine studies in long-term care found light therapy improved sleep efficiency (effect size 0.67, 95% CI 0.13 to 1.21), with the largest effects for 5,000 lux or more and for sessions under an hour, though variation between studies was high. One of its nine studies took the light to the resident on the body: by the review's table, a US nursing-home trial (a 2008 dissertation) randomised 20 women with mild to moderate dementia, 10 of them to blue light at 12,000 lux from a cap visor for half an hour each morning for two weeks. In US assisted living, a randomised crossover feasibility trial of amber LED strips around the bathroom doorframe (built to steady residents at night, not to set the body clock) found 34% fewer night-time falls than with standard nightlights (incidence density ratio 0.66, 95% CI 0.35 to 1.22, not significant). Families were highly satisfied, and a larger trial is under way.

What would unlock progress

Light that reaches each resident where they are, set up and run by the home rather than a research team, and a way to know each resident's dose without depending on a sensor the resident must keep on. Two of the positive trials placed light by each resident or measured each resident's dose; the systems homes buy light a room on one schedule. Wearable sensors already exist and show that room readings mislead. What they have not solved is wear: residents with dementia lose, break or remove them, and much of the night-time data is missing. Two openings follow. One is a dose estimate that does not ride on the body, for example sensors fixed at the bed head, chair or wheelchair at eye height, checked against a worn sensor. The other is a light source fixed to the bed, chair or wheelchair that delivers a dose at the eye without the hour-long sitting a light box needs.

How we’d know it’s being solved

(a) Each resident's light at eye level per day (lux and, ideally, melanopic or circadian-stimulus value) compared with the dose the schedule was meant to deliver, with the hours of missing data reported, especially at night; (b) in a trial, change in actigraphy-measured rest-activity stability and fragmentation and night-time awakenings against standard light, analysed by the dose each resident actually received; (c) staff minutes needed to deliver it and to keep any sensor working. Beware the proxy: lux measured at the luminaire or in the living room is not light at the resident's eye.

Where to start

Facility-free door: start from existing research light loggers (such as the collar-worn sensor used in the US nursing-home studies), not from a new wearable. Access line: a team borrows the logger from a campus lab that studies lighting or sleep; without one, this door cannot start. On team members, record a week with one worn at the collar and cheap fixed sensors placed at eye height on a bed head, an armchair and a desk chair. Test how well the fixed sensors, combined with a simple log of where the person was, predict the worn reading. That shows whether a non-worn method could stand in for the sensors residents remove, and compare the result with the room schedule published in the Dutch trial. A second round can repeat it with consenting older adults at a senior centre, whose days include more sitting. What carries over is the method: how far fixed sensors sit from the eye reading, for which positions, and how much a location log helps. What does not carry over is the residents' own day (long hours in bed, very low activity, depending on staff to get up), so the result calibrates the method; it does not estimate any resident's dose. Object door: design a light source that comes to the resident rather than the room, for example one fixed to a bed, chair or wheelchair. It should deliver a dose at the eye without an hour of sitting still, differ from ceiling biodynamic systems, light boxes and the floor lamps and light tables in the US trial on exactly that point, and from the cap-visor light in What's Been Tried by not being worn, and be something staff do not have to place each day. A light box clamped near the bed does not meet this on its own: the test is the dose at the eye in the positions a resident spends the day in (lying in bed, sitting in a chair), measured with the worn logger from the first door. Test glare, comfort and tolerance in supervised sessions with consenting older adults without dementia at a senior centre; it is not tested with residents. Before recruiting, the campus ethics office reviews the session plan. Light at the eye stays within the levels used in the trials on this page, the tester can turn it off or look away at any time, and people with eye disease, recent eye surgery, migraine, epilepsy or light-sensitising medication do not take part. Those sessions show whether the light is bearable and reaches the eye; whether staff can run it and whether residents in bed take in the dose is left to the trial below. Trial-design door: design, do not run, a nursing-home study that compares a worn sensor with the fixed-sensor estimate and logs napping and time in bed alongside actigraphy, analysing outcomes by dose received. Residents with dementia cannot give consent in the usual way. The design therefore needs ethics review, consent from legal representatives plus the resident's own assent, a rule for stopping when a resident shows distress or keeps removing a device, and a nursing-home partner. Relevant skills: lighting design, embedded sensing, product design for care settings, sleep science.

Genes

Related problems

Stuck the same way, in other fields.

field: food & the living worldfresh at dawn, half price by duskIn small-scale fisheries the fish is rarely thrown away — it is sold for half price as it warms, and no one can objectively grade the quality being lostbuilt without the people who'd live with itsource: primaryfield: making & materialsless copper per tonne, more energy to get itCopper ore grade decline creates compounding energy-emissions processing spiralbuilt without the people who'd live with itsource: secondaryfield: society & learningno desk, no team in sightOffices without assigned desks are often introduced to increase interaction, but in a controlled study at a Swedish agency satisfaction with communication among close colleagues fell and stayed lower a year later, which the authors tie to trouble locating colleagues, and university staff in two Swedish relocations reported less social community, and in one of them not knowing where to find colleaguesbuilt without the people who'd live with itsource: primaryfield: making & materialsno plastic, heavier traysFrance banned plastic cooking, reheating and serving containers in school canteens from 2025, but the national catering council's own guide finds no plastic-free fibre tray on the market, gives no compliant material top marks for weight, and flags lid handling and container washing as strain risks for kitchen staffbuilt without the people who'd live with itsource: primary

Sources

  • Prins AJ, de Boer B, Milders MV, Scherder EJA. "Biodynamic lighting versus bright light effects on rest-activity rhythm and night-time sleep in nursing homes residents with dementia." BMC Geriatrics 2026, doi:10.1186/s12877-026-07365-2, accessed 2026-11-17. Link ↗
  • Baandrup L, Jennum PJ. "Effect of a dynamic lighting intervention on circadian rest-activity disturbances in cognitively impaired, older adults living in a nursing home: A proof-of-concept study." Neurobiology of Sleep and Circadian Rhythms 2021, doi:10.1016/j.nbscr.2021.100067, accessed 2026-11-17. Link ↗
  • Cheon IS, Lee SH, Chae YR. "[Effects of light therapy on sleep efficiency in older adults in long-term care facilities: a systematic review and meta-analysis]." Journal of Korean Biological Nursing Science 2025, doi:10.7586/jkbns.25.071 (Korean full text), accessed 2026-11-17. Link ↗
  • Crowley P, O'Donovan MR, Leahy P, Flanagan E, O'Caoimh R. "Pharmacological and Non-Pharmacological Interventions to Improve Sleep in People with Cognitive Impairment: A Systematic Review and Meta-Analysis." International Journal of Environmental Research and Public Health 2025, doi:10.3390/ijerph22060956, accessed 2026-11-17. Link ↗
  • Zimmerman S, Sloane PD, Preisser JS, Ward K, Wretman CJ, Davis SA, Figueiro MG. "Feasibility of a Novel Lighting System to Reduce Nighttime Falls in Assisted Living Residents With Dementia." Journal of the American Medical Directors Association 2024, doi:10.1016/j.jamda.2024.105227 (author manuscript), accessed 2026-11-17. Link ↗
  • Figueiro MG, Plitnick B, Roohan C, Sahin L, Kalsher M, Rea MS. "Effects of a Tailored Lighting Intervention on Sleep Quality, Rest-Activity, Mood, and Behavior in Older Adults With Alzheimer Disease and Related Dementias: A Randomized Clinical Trial." Journal of Clinical Sleep Medicine 2019;15:1757-1767, doi:10.5664/jcsm.8078, accessed 2026-11-17. Link ↗
  • Hjetland GJ, Kolberg E, Pallesen S, Thun E, Nordhus IH, Bjorvatn B, Flo-Groeneboom E. "Ambient bright light treatment improved proxy-rated sleep but not sleep measured by actigraphy in nursing home patients with dementia: a placebo-controlled randomised trial." BMC Geriatrics 2021;21:312, doi:10.1186/s12877-021-02236-4, accessed 2026-11-17. Link ↗
  • Beiglary S, Feng Y, Wang N, Ghaeili N, Jao YL, Liao YJ, Li Y, Wang J. "Using Wearable Sensors to Measure and Predict Personal Circadian Lighting Exposure in Nursing Home Residents: Model Development and Validation." JMIR Aging 2025;8:e72338, doi:10.2196/72338, accessed 2026-11-17. Link ↗
  • Jao YL, Wang J, Beiglary S, Liao YJ. "Measuring lighting using an individual wearable light sensor in nursing home residents with dementia." Innovation in Aging 2024;8(Suppl 1):798, doi:10.1093/geroni/igae098.2591 (conference abstract), accessed 2026-11-17. Link ↗
  • Jao YL, Liao YJ, Berish D, Wang J, Calkins M, Kuan YH, Ndurue L, Boltz M. "Measuring light exposure in nursing home residents with dementia: facility-level measures vs wearable sensor." Innovation in Aging 2025;9(Suppl 2):igaf122.3289, doi:10.1093/geroni/igaf122.3289 (conference abstract), accessed 2026-11-17. Link ↗
  • Jao YL, Wang J, Liao YJ, Berish D, Boltz M, Calkins M. "IMPLEMENTING SMART AMBIENT BRIGHT LIGHT (SABL) IN NURSING HOME RESIDENTS WITH DEMENTIA: CHALLENGES AND STRATEGIES." Innovation in Aging 2023;7(Suppl 1):706-707, doi:10.1093/geroni/igad104.2292 (conference abstract), accessed 2026-11-17. Link ↗
  • Lin CJ, Liao YJ, Berish D, Jao YL. "EFFECTS OF SMART AMBIENT BRIGHT LIGHT (SABL) ON SLEEP QUALITY IN NURSING HOME RESIDENTS WITH DEMENTIA." Innovation in Aging 2024;8(Suppl 1):722-723, doi:10.1093/geroni/igae098.2356 (conference abstract), accessed 2026-11-17. Link ↗
  • Jao YL, Berish D, Liao YJ, Wang J, Boltz M, Kuan YH, Ndurue L, Calkins M. "Smart Ambient Bright Light for Nursing Home Residents With Dementia: Neurobehavioral Symptom Impact." Innovation in Aging 2025;9(Suppl 2):igaf122.1154, doi:10.1093/geroni/igaf122.1154 (conference abstract), accessed 2026-11-17. Link ↗
  • Jao Y, Liao Y, Berish D, Wang J. "Smart Ambient Bright Light in Nursing Homes: Impact on Individual Light Exposure and Dementia-related Symptoms." Alzheimer's & Dementia 2025;21(Suppl 7):e108600, doi:10.1002/alz70861_108600 (conference abstract), accessed 2026-11-17. Link ↗
Revision notes

This brief gets checked against its sources and contains the following revisions. Future revisions get added here.

Worth knowing

  • The Dutch trial was small, not randomised and, by its authors' account, underpowered; the role of care routines is the authors' suggestion.
  • The findings on worn light sensors come mostly from conference abstracts, with one full paper.

Full check

Sources read

  • Prins et al., biodynamic versus bright light in a Dutch nursing home (BMC Geriatrics, 2026): full text
  • Baandrup and Jennum, dynamic lighting in residents' apartments (Neurobiology of Sleep and Circadian Rhythms, 2021): full text
  • Hjetland et al., ambient bright light trial in Norway (BMC Geriatrics, 2021): full text
  • Figueiro et al., tailored lighting trial (Journal of Clinical Sleep Medicine, 2019): full text
  • Beiglary et al., wearable light sensors in nursing homes (JMIR Aging, 2025): full text
  • Crowley et al., review of sleep treatments in cognitive impairment (IJERPH, 2025): full text
  • Cheon et al., meta-analysis of light therapy in long-term care (2025): full text (read in Korean)
  • Zimmerman et al., doorframe lighting and night-time falls (JAMDA, 2024): full text (the author manuscript)
  • Jao, Lin and colleagues, six conference abstracts on a daylight-linked lighting system and worn sensors (2023–2025): full text (each a conference abstract, read whole)

What changed

  • Stated more strongly than the source: that the positive trials all placed light by each resident or measured each resident's dose; two of them did, while others on the page did neither; the collar-worn sensor was said to be used in US nursing-home trials; the sources describe one trial and two other studies.
  • Numbers: the measured dose (268 lux) and room readings (85–114 lux) came from a different group of 29 residents, not the 27 in the trial; the page now says so.
  • Title: the long title now says a US trial (one, not several) that put light where each resident sat did better; display title unchanged.

Left open

None noted in this check.

Separate check of specific claims: The build starting point now has an eye-safety and ethics line for testing a light with older adults, and the free starting point says where a team gets a research light logger.

Separate check of specific claims: A cap-visor light trial from the Korean review was added (design only), and the build starting point now asks for a light that is not worn.

Earlier full check: A stitched quotation from the Dutch authors was replaced by their full sentence, 'US trials' became 'a US trial', an unsourced mention of sold light loggers was removed, conference abstracts were added to the source list, and the long title now says care routines may have kept many residents in bed (display title unchanged).

Separate check of specific claims: The free starting point gained a senior-centre round and a line on what carries over to residents, and the build starting point now requires the light to reach the eye in lying and sitting positions, with consent for testers.

Earlier full check: The page now starts from two things already tried (light placed by each resident, which did better in a US trial, and worn light sensors, many of which were lost or removed), a Norwegian trial was added, the Dutch result is stated with its limits, a claim that neither trial measured light at the eye was dropped (one did), and the long title was changed (display title unchanged).